Success Metrics

Clinical Success Rate
78.8%

Based on 508 completed trials

Completion Rate
79%(508/645)
Active Trials
390(33%)
Results Posted
63%(320 trials)
Terminated
137(11%)

Phase Distribution

Ph not_applicable
351
29%
Ph early_phase_1
24
2%
Ph phase_1
128
11%
Ph phase_2
349
29%
Ph phase_3
201
17%
Ph phase_4
6
1%

Phase Distribution

152

Early Stage

349

Mid Stage

207

Late Stage

Phase Distribution1059 total trials
Early Phase 1First-in-human
24(2.3%)
Phase 1Safety & dosage
128(12.1%)
Phase 2Efficacy & side effects
349(33.0%)
Phase 3Large-scale testing
201(19.0%)
Phase 4Post-market surveillance
6(0.6%)
N/ANon-phased studies
351(33.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

70.5%

508 of 721 finished

Non-Completion Rate

29.5%

213 ended early

Currently Active

390

trials recruiting

Total Trials

1,192

all time

Status Distribution
Active(392)
Completed(508)
Terminated(213)
Other(79)

Detailed Status

Completed508
Active, not recruiting259
Terminated137
Recruiting131
Withdrawn76
unknown70

Development Timeline

Analytics

Development Status

Total Trials
1192
Active
390
Success Rate
78.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 124 (2.3%)
Phase 1128 (12.1%)
Phase 2349 (33.0%)
Phase 3201 (19.0%)
Phase 46 (0.6%)
N/A351 (33.1%)

Trials by Status

active_not_recruiting25922%
unknown706%
recruiting13111%
suspended91%
terminated13711%
completed50843%
withdrawn766%
not_yet_recruiting20%

Recent Activity

Clinical Trials (1,192)

Showing 20 of 1,192 trialsScroll for more
NCT04267796Not Applicable

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

Active Not Recruiting
NCT05642611Phase 3

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Recruiting
NCT03634241Phase 2

Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

Completed
NCT06058377Phase 3

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Recruiting
NCT03574792Phase 2

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Completed
NCT02615275Not Applicable

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Active Not Recruiting
NCT04829539Phase 3

Comparing Brief Behavioral Therapy (BBT-CI) and Healthy Eating Education Learning (HEAL) for Cancer-Related Sleep Problems While Receiving Cancer Treatment

Recruiting
NCT02863107

Young-Onset Colorectal Cancer

Active Not Recruiting
NCT04789681Phase 2

Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial

Recruiting
NCT04783168Not Applicable

Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study

Recruiting
NCT02481349Not Applicable

Couples-Based Yoga Program in Improving Quality of Life in Patients With High-Grade Glioma Undergoing Radiation Therapy and Their Partners

Active Not Recruiting
NCT03175432Phase 2

Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Active Not Recruiting
NCT04693377Not Applicable

Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial

Recruiting
NCT04195399Phase 2

A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery

Active Not Recruiting
NCT03948100Not Applicable

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

Recruiting
NCT04003051Phase 2

Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies

Recruiting
NCT04053517

Financial Distress in Advanced Cancer Patients

Active Not Recruiting
NCT05136807

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

Recruiting
NCT05036330

ProvoxLife Adoption Trends for Heat-Moisture Exchanger

Active Not Recruiting
NCT05428176Not Applicable

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

Active Not Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
1,192